XM tidak memberikan layanan kepada penduduk Amerika Serikat.
A
A

Assurant


Berita

U.S. Aadi Bioscience, Target, Visteon

U.S. RESEARCH ROUNDUP-Aadi Bioscience, Target, Visteon Aug 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aadi Bioscience, Target and Visteon, on Thursday. HIGHLIGHTS * Aadi Bioscience Inc AADI.O : Jefferies cuts to hold from buy * Assurant Inc AIZ.N : Piper Sandler cuts to neutral from overweight * Estée Lauder EL.N : Piper Sandler raises to overweight from neutral * Target Corp TGT.N : Jefferies raises target
A
A
H
S
T
T
U
A
P
U
D
E
A

U.S. Agenus, Guardant Health, Zoetis

U.S. RESEARCH ROUNDUP-Agenus, Guardant Health, Zoetis Aug 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Agenus, Guardant Health and Zoetis, on Wednesday. HIGHLIGHTS * Agenus Inc AGEN.O : B. Riley cuts target price to $18 from $42 * Clorox CLX.N : Jefferies raises target price to $151 from $148 * Guardant Health Inc GH.O : Raymond James raises target price to $36 from $28 * Starbucks SBUX.O : Stifel raises to buy
A
C
D
E
I
E
A
A
C
E

U.S. Apollo, Blackstone, Hershey

U.S. RESEARCH ROUNDUP- Apollo, Blackstone, Hershey Aug 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Apollo, Blackstone and Hershey, on Tuesday. HIGHLIGHTS * Apollo APO.N : Jefferies cuts target price to $114 from $129 * Blackstone BX.N : Jefferies raises target price to $147 from $138 * Hershey Co HSY.N : Goldman Sachs initiates coverage with sell rating * Palomar Holdings Inc PLMR.O : KBW raises target price to
A
A
A
A

U.S. Amphastar Pharmaceuticals, G1 Therapeutics, Upwork

U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, G1 Therapeutics, Upwork Aug 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amphastar Pharmaceuticals, G1 Therapeutics and Upwork on Thursday. HIGHLIGHTS * Amphastar Pharmaceuticals Inc AMPH.O : Piper Sandler cuts target price to $66 from $71 * Charles River Laboratories International Inc CRL.N : Baird cuts to neutral * G1 Therapeutics Inc GTHX.O : H.C.
A
A
C
G
A
C
I

Assurant Inc reports results for the quarter ended in June - Earnings Summary

Assurant Inc reports results for the quarter ended in June - Earnings Summary Assurant Inc AIZ.N reported quarterly adjusted earnings of $4.08​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $3.89. The mean expectation of eight analysts for the quarter was for earnings of $3.62 per share.
A

Assurant's profit jumps on global housing unit strength, higher investment returns

Assurant's profit jumps on global housing unit strength, higher investment returns Aug 6 (Reuters) - Insurer Assurant AIZ.N reported a 21% jump in second-quarter profit on Tuesday, driven by growth in its global housing segment and higher investment returns. The company's global housing unit, which offers lender-placed homeowners, manufactured housing and flood insurance, posted net earned premiums, fees and other income of $633.6 million, an 18% jump over the year earlier.
U
A

Assurant Q2 Adjusted EPS USD 4.08 Vs. IBES Estimate USD 3.62

BRIEF-Assurant Q2 Adjusted EPS USD 4.08 Vs. IBES Estimate USD 3.62 Aug 06 (Reuters) - Assurant Q2 net income USD 188.7 million. Q2 adjusted EBITDA USD 323.4 million Q2 EPS USD 3.58
A

Assurant Inc <AIZ.N> expected to post earnings of $3.62 a share - Earnings Preview

Assurant Inc expected to post earnings of $3.62 a share - Earnings Preview Assurant Inc AIZ.N , AIZ is expected to show a rise in quarterly revenue when it reports results on August 6 for the period ending June 30 2024 The Atlanta Georgia-based company is expected to report a 5.9% increase in revenue to $2.893 billion from $2.73 billion a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
A

Assurant Expects Global Housing Segment To Record About $46 Million Pre-Tax Of Reportable Catastrophes For Q2

BRIEF-Assurant Expects Global Housing Segment To Record About $46 Million Pre-Tax Of Reportable Catastrophes For Q2 July 15 (Reuters) - Assurant Inc AIZ.N : ASSURANT INC - EXPECTS GLOBAL HOUSING SEGMENT TO RECORD ABOUT $46 MILLION PRE-TAX OF REPORTABLE CATASTROPHES FOR Q2 2024 Source text for Eikon: [ID:n0001267238-24-000033] Further company covera
A

Assurant Announces Global Auto Leadership Succession Plan

BRIEF-Assurant Announces Global Auto Leadership Succession Plan July 9 (Reuters) - Assurant Inc AIZ.N : ASSURANT ANNOUNCES GLOBAL AUTO LEADERSHIP SUCCESSION PLAN Source text for Eikon: ID:nBw1tYJxHa Further company coverage: AIZ.N
A



Kondisi

Aset Populer

Pengungkapan: Entitas XM Group menyediakan layanan khusus eksekusi dan akses ke Fasilitas Trading Online kami, yang memungkinkan Anda untuk melihat dan/atau menggunakan konten yang tersedia pada atau melalui situs, yang tidak untuk mengubah atau memperluas, serta tidak mengubah atau memperluas hal tersebut. Akses dan penggunaan ini selalu sesuai dengan: (i) Syarat dan Ketentuan; (ii) Peringatan Risiko; dan (iii) Pengungkapan Penuh. Oleh karena itu, konten disediakan hanya sebagai informasi umum. Anda juga harus ketahui bahwa konten Fasilitas Trading Online kami bukan sebagai ajakan atau tawaran untuk untuk melakukan transaksi apa pun di pasar finansial. Trading di pasar finansial mana pun melibatkan tingkat risiko yang signifikan pada modal Anda.

Semua materi yang diterbitkan di Fasilitas Trading Online kami hanya untuk tujuan edukasi/informasi dan tidak boleh mengandung nasihat dan rekomendasi finansial, pajak investasi atau trading, catatan harga trading kami, penawaran, permintaan, transaksi dalam instrumen finansial apa pun atau promo finansial untuk Anda yang tidak diminta.

Konten pihak ketiga apa pun, serta konten yang disiapkan oleh XM, seperti opini, berita, riset, analisis, harga, informasi lain atau link ke situs pihak ketiga yang tersedia "sebagaimana adanya", sebagai komentar pasar umum dan bukan menjadi nasihat investasi. Sejauh konten apa pun ditafsirkan sebagai penelitian investasi, Anda harus memperhatikan dan menerima bahwa konten tersebut tidak dimaksudkan dan belum disiapkan sesuai dengan persyaratan hukum yang dirancang untuk mempromosikan kemandirian riset investasi dan dengan demikian akan dianggap sebagai komunikasi pemasaran di bawah hukum dan peraturan yang relevan. Mohon dipastikan bahwa Anda telah membaca dan memahami Notifikasi pada Riset Investasi Non-Independen dan Peringatan Risiko kami mengenai informasi di atas, yang dapat diakses disini.

Peringatan Resiko: Modal Anda beresiko. Produk dengan leverage mungkin tidak cocok bagi semua orang. Silahkan pertimbangkan Pengungkapan Resiko kami.